Latest News

MYRIAD: Anesthesia methods lead to similar outcomes in CABG




Among patients undergoing elective CABG, there was no difference in 1-year mortality between those assigned IV anesthesia and those assigned a volatile anesthetic, according to the results of the MYRIAD trial.
The researchers randomly assigned 5,400 patients (mean age, 62 years; 19% women) undergoing isolated elective CABG at 36 centers in 13 countries to total IV anesthesia or an intraoperative regimen including a volatile anesthetic such as desflurane, isoflurane or sevoflurane. The results were presented at the International Symposium on Intensive Care and Emergency Medicine and published

Source link




Related posts

STAT Plus: Pharmalittle: FDA approves a record number of generics; Bristol-Myers’ Opdivo fails lung cancer study goal

Newsemia

‘Remain vigilant, remain resolved’

Newsemia

Global In Vitro Lung Model Market Analysis and Outlook: 2019-2025 – ResearchAndMarkets.com

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy